That's the problem. Dr. Alkon and his research team are doing an incredible job, but I wonder what the other executives are doing other than writing reports and making sweetheart deals with high net worth individuals so they can cash in some cheap warrants while existing shareholders get screwed.
Hopefully the stock price stays low enough for those older 5 million warrants to expire worthless in November 2021.
News 
Market Data 
Discover 
